Our specialist team will conduct a comprehensive metabolic, hormonal, and longevity assessment to determine which GLP-1 therapy or combination of therapies is most appropriate for your individual health profile and goals
Table 12: Study of Different Times of Once Daily Insulin Glargine Dosing in Type 1 (Study H) and Type 2 (Study I) Diabetes Mellitus Insulin glargine was compared to NPH insulin in a 5-year randomized clinical study that evaluated the progression of retinopathy as assessed with fundus photography using a grading protocol derived from the Early Treatment Diabetic Retinopathy Scale (ETDRS)
2019;35(7):e3168
Better depends on safety, availability, medical history, side effects, and provider guidance
[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Porter L.C., Franczyk M.P., Pietka T., Yamaguchi S., Lin J.B., Sasaki Y., Verdin E., Apte R.S., Yoshino J